[HTML][HTML] Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European …
Background Although health technology assessment (HTA) systems base their decision
making process either on economic evaluations or comparative clinical benefit assessment …
making process either on economic evaluations or comparative clinical benefit assessment …
[HTML][HTML] Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare
B Jönsson, G Hampson, J Michaels, A Towse… - The European journal of …, 2019 - Springer
Background Advanced therapy medicinal products (ATMPs) are beginning to reach
European markets, and questions are being asked about their value for patients and how …
European markets, and questions are being asked about their value for patients and how …
[HTML][HTML] Similarities and differences in health technology assessment systems and implications for coverage decisions: evidence from 32 countries
AM Fontrier, E Visintin, P Kanavos - PharmacoEconomics-open, 2022 - Springer
Health technology assessment (HTA) systems across countries vary in the way they are set
up, according to their role and based on how funding decisions are reached. Our objective …
up, according to their role and based on how funding decisions are reached. Our objective …
[HTML][HTML] Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to …
E Nicod - The European Journal of Health Economics, 2017 - Springer
Purpose Health technology assessment (HTA) coverage recommendations differ across
countries for the same drugs. Unlike previous studies, this study adopts a mixed methods …
countries for the same drugs. Unlike previous studies, this study adopts a mixed methods …
[HTML][HTML] Advanced therapy medicinal products: value judgement and ethical evaluation in health technology assessment
E Gonçalves - The European Journal of Health Economics, 2020 - Springer
Advanced therapy medicinal products (ATMPs) are a heterogeneous class of medicinal
products that by offering the potential of cure represent a paradigm shift in the approach of …
products that by offering the potential of cure represent a paradigm shift in the approach of …
[HTML][HTML] The HTA Core Model®—10 years of developing an international framework to share multidimensional value assessment
Abstract Background and Objectives The HTA Core Model® as a science-based framework
for assessing dimensions of value was developed as a part of the European network for …
for assessing dimensions of value was developed as a part of the European network for …
Evaluating the quality of evidence from a network meta-analysis
BACKGROUND: In July 2013 the Department of Health referred terms of reference for value
based assessment of health technologies to NICE. OBJECTIVE: We present the approach …
based assessment of health technologies to NICE. OBJECTIVE: We present the approach …
[HTML][HTML] Health technology assessment (HTA) case studies: factors influencing divergent HTA reimbursement recommendations in Australia, Canada, England, and …
N Allen, SR Walker, L Liberti, S Salek - Value in Health, 2017 - Elsevier
Objectives To evaluate the national regulatory, health technology assessment (HTA), and
reimbursement pathways for public health care in Australia, Canada, England, and …
reimbursement pathways for public health care in Australia, Canada, England, and …
[HTML][HTML] Differences in health technology assessment recommendations among European jurisdictions: the role of practice variations
RA Vreman, AK Mantel-Teeuwisse, AM Hövels… - Value in Health, 2020 - Elsevier
Background Health technology assessment (HTA) plays an important role in reimbursement
decision-making in many countries, but recommendations vary widely throughout …
decision-making in many countries, but recommendations vary widely throughout …
[引用][C] Assessing the clinical and cost-effectiveness of medical devices and drugs: are they that different?
RS Taylor, CP Iglesias - Value in Health, 2009 - Elsevier
The term “medical device” covers a wide range of technology. According to the European
Union (EU) directive 2007/47/EC, a “medical device” is defined as “any instrument …
Union (EU) directive 2007/47/EC, a “medical device” is defined as “any instrument …